MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

CTSO — Cytosorbents Corp.

Nasdaq

Cytosorbents Corp.

CompareBack to Screener
$4.05
-0.14(-3.23%)
O
4.17
H
4.29
L
3.83
V
12.54K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Cytosorbents Corp. Statistics

Total Valuation

Market Cap$12.76M
Enterprise Value$12.78M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding3.15M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ration/a
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-2,491.56
EV / Salesn/a
EV / EBITDA-4,789.81
EV / EBIT-2,991.39
EV / FCF-10,355.92

Financial Position

Current Ratio1.09
Quick Ration/a
Debt / Equity10.06
Debt / EBITDA-8.27
Debt / FCF-17.88
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)-233.77%
Return on Assets (ROA)-12.64%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-40
Employee Count129
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+311.17%
50-Day Moving Average$2.36
200-Day Moving Average$1.03
Relative Strength Index (RSI)14.06
Average Volume (20 Days)13,120

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$6.13K
Operating Income-$3.04K
Pretax Income-$5.13K
Net Income-$5.13K
EBITDA-$2.67K
EBIT-$4.27K
Loss Per Share$-0.08

Balance Sheet

Cash & Cash Equivalents$4.81K
Total Debt$22.07K
Net Cash-$17.25K
Net Cash Per Share$-0.01
Equity (Book Value)$2.19K
Book Value Per Share$0.00
Working Capital$1.45K

Cash Flow

Operating Cash Flow-$2.88K
Capital Expenditures$15
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$1.23K
FCF Per Share$-0.00

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield-0.01%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a